Bullous Pemphigoid Learning Hub

Welcome to the BP learning hub focused on key scientific education on bullous pemphigoid, featuring ADVENT resources.

Bullous pemphigoid (BP) is a chronic relapsing autoimmune skin disease characterized by intense itch, inflammatory lesions, and blister formation. View the resources below to learn about a variety of topics related to BP.

Clinical Presentation, Diagnosis and Burden of BP

Understand the clinical presentation, diagnostic challenges and burden of BP.

Dermatology

2 min

expert video

Etiology and Diagnosis of Bullous Pemphigoid

Explore the clinical presentations of bullous pemphigoid (BP), the steps for diagnosis, and the burden of disease.

Dermatology

10 min

Infographic

Bullous Pemphigoid (BP): Don't Miss the Diagnosis

Diagnosis of Bullous Pemphigoid Interactive Patient Case

Dermatology

10 min

interactivity

Diagnosis of Bullous Pemphigoid Interactive Patient Case

Unmet Needs in BP

Gain insights into the unmet needs faced by patients with BP.

Dermatology

10 min

expert video

Unmet Needs and Management Challenges in Bullous Pemphigoid (BP)

Test your knowledge

Check your understanding of the latest clinical insights and disease management.

MAT-GLB-2506643 - 1.0 - 11/2025

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region